A Single Dose Bioequivalence Study OfTwo Formulations Of Nicotine Lozenges
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
Open label, single dose, four-way crossover in healthy smokers. Each subject will be treated
with a single dose or four study treatments in a randomized sequence.